John Mcgee ^Investor

John McGee is a highly accomplished Scientific Founder and Head of De Novo Discovery at FogPharma, with a strong background in biochemistry and chemistry. With a PhD from Harvard University and experience as a Postdoctoral Fellow at Harvard, he brings a wealth of knowledge and expertise to his role. John is passionate about driving innovation and discovery in the scientific field, and has a proven track record of success in leading research and development projects. His dedication to advancing scientific knowledge and pushing boundaries makes him a valuable asset to any organization.